SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Morgan Stanley Raises BeiGene Price Target to $476 From $465

Valid market news retained in the public archive without immediate LiveCast distribution.

ONC

Related stories